ArticlePloS one2017

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.

Paola Brun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.